当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析

山东药玻

(600529)

  

流通市值:138.76亿  总市值:138.76亿
流通股本:6.64亿   总股本:6.64亿

山东药玻(600529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.42亿元,每股收益0.82元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益814907.46万元,未分配利润411968.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产988235.47万元,负债173328.01万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,400,516,917.762,373,844,830.371,242,455,243.55,125,270,640.68
营业总成本2,707,149,986.221,901,614,186.9982,600,179.314,013,019,482.72
其他经营收益
营业利润651,866,577.9444,092,441.69266,839,417.51,112,760,817.8
利润总额648,391,295.8441,547,642.49266,914,530.671,110,805,053.19
净利润542,453,658.37371,141,622223,629,434.88942,991,305.41
每股收益
其他综合收益----
综合收益总额542,453,658.37371,141,622223,629,434.88942,991,305.41
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,796,596,188.315,906,627,859.566,054,844,132.515,980,458,741.73
非流动资产:
非流动资产合计4,085,758,516.844,068,834,718.964,118,521,689.114,159,550,624.11
资产总计9,882,354,705.159,975,462,578.5210,173,365,821.6210,140,009,365.84
流动负债:
流动负债合计1,605,866,076.131,680,931,466.041,813,628,913.032,000,567,167.16
非流动负债:
非流动负债合计127,414,007.84129,989,449129,451,043.52131,672,508.13
负债合计1,733,280,083.971,810,920,915.041,943,079,956.552,132,239,675.29
所有者权益(或股东权益):
归属于母公司股东权益合计8,149,074,621.188,164,541,663.488,230,285,865.078,007,769,690.55
股东权益合计8,149,074,621.188,164,541,663.488,230,285,865.078,007,769,690.55
负债和股东权益合计9,882,354,705.159,975,462,578.5210,173,365,821.6210,140,009,365.84
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,029,175,063.032,655,036,091.171,328,700,650.065,238,740,917.65
经营活动现金流出小计3,518,218,534.812,355,595,344.521,238,167,440.494,073,690,549.75
经营活动产生的现金流量净额510,956,528.22299,440,746.6590,533,209.571,165,050,367.9
投资活动产生的现金流量:
投资活动现金流入小计6,156,698,640.544,387,693,186.491,598,445,580.56,489,936,751.09
投资活动现金流出小计6,515,042,423.884,573,845,660.911,588,412,908.917,607,785,101.03
投资活动产生的现金流量净额-358,343,783.34-186,152,474.4210,032,671.59-1,117,848,349.94
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计370,341,793.4180,554,602.56-464,529,879.1
筹资活动产生的现金流量净额-370,341,793.4-180,554,602.56--464,529,879.1
汇率变动对现金及现金等价物的影响7,322,055.647,833,614.043,842,789.2915,608,495.17
现金及现金等价物净增加额-210,406,992.88-59,432,716.29104,408,670.45-401,719,365.97
期末现金及现金等价物余额674,774,368.83825,748,645.42989,590,032.16885,181,361.71
补充资料:
现金及现金等价物的净增加额--59,432,716.29--401,719,365.97
最新报告期:2025-11-04
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长江证券李浩,范超1.121.271.412025-11-04
东兴证券赵军胜1.121.331.552025-11-03
申万宏源任杰,宋涛,郝子禹1.201.381.522025-10-28
中信证券陈竹,韩世通1.281.461.652025-09-05
长江证券李浩,范超1.191.351.512025-09-02
TOP↑